Clinical Trial Update: Extension Study to Evaluate Safety and Efficacy of CTP-543 in Adults With Alopecia Areata [Phase 2, Phase 3]

View source ↗

Summary

This document provides an update on an extension study of CTP-543 for alopecia areata. The study spans Phase 2 and Phase 3 and is currently active but not recru…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Alopecia Areata

Drugs mentioned

• CTP-543

Snippet

Sponsor: Sun Pharmaceutical Industries, Inc. | Conditions: Alopecia Areata | Phase 2, Phase 3 | Status: ACTIVE_NOT_RECRUITING